These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10616518)

  • 1. Anticardiolipin antibodies in hemodialysis patients.
    Ozdemir N; Güz G; Sezer S; Haberal A; Ayaz H; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3388-9. PubMed ID: 10616518
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticardiolipin antibodies in patients on regular hemodialysis: an epiphenomenon?
    Sitter T; Schiffl H
    Nephron; 1993; 64(4):655-6. PubMed ID: 8367001
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between anticardiolipin antibodies and vascular access occlusion in patients on hemodialysis.
    Gültekin F; Alagözlü H; Candan F; Nadir I; Bakici MZ; Sezer H
    ASAIO J; 2005; 51(2):162-4. PubMed ID: 15839442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
    Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
    Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of anticardiolipin antibodies in renal transplant recipients.
    Oymak O; Erdem Y; Yalcin AU; Yasavul U; Turgan C; Cağlar S
    Nephron; 1995; 71(4):469-70. PubMed ID: 8587633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance].
    Ferlazzo B; Barrile A; Bonanno D; Quattrocchi P; Santoro D; Savica V; Bellinghieri G
    Recenti Prog Med; 1998 Sep; 89(9):434-7. PubMed ID: 9796372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients.
    Phillips AO; Jones HW; Hambley H; Hillis AN; Hendry BM
    Nephron; 1993; 65(3):350-3. PubMed ID: 8289982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies and lipoprotein (a) levels in patients with chronic renal failure treated with dialysis: associations with atherothrombotic disease.
    Petersen LJ; Ringsdal VS; Ladefoged SD; Baslund B; Hansen PR
    Int J Artif Organs; 1996 Jun; 19(6):339-42. PubMed ID: 8814496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low seroconversion rates in CAPD patients compared to hemodialysis patients: potential advantages for transplant candidates.
    Akpolat T; Dilek M; Yavuz M; Utas C; Ozener C; Karayaylali I; Yilmaz E; Ersoy F; Camsari T; Ataman R; Bozfakioglu S; Akcicek F; Ates K; Arinsoy T;
    Perit Dial Int; 2002; 22(4):520-3. PubMed ID: 12322827
    [No Abstract]   [Full Text] [Related]  

  • 11. Are antiphospholipid antibodies clinically relevant in dialysis patients?
    Chew SL; Lins RL; Daelemans R; Zachee P; De Clerck LS; Vermylen J
    Nephrol Dial Transplant; 1992; 7(12):1194-8. PubMed ID: 1337159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin antibodies in children on chronic haemodialysis.
    Sallam S; Wafa E; el-Gayar A; Sobh M; Salama O
    Nephrol Dial Transplant; 1994; 9(9):1292-4. PubMed ID: 7816292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients.
    Chuang FR; Chen TC; Yang CC; Cheng YF; Hsu KT; Lee CH; Lin CL; Wang IK; Chang HW; Wang PH
    Ren Fail; 2005; 27(1):25-30. PubMed ID: 15717631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients.
    Roozbeh J; Serati AR; Malekhoseini SA
    Arch Iran Med; 2006 Jan; 9(1):26-32. PubMed ID: 16649374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.
    Prakash R; Miller CC; Suki WN
    Am J Kidney Dis; 1995 Aug; 26(2):347-52. PubMed ID: 7645540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the anticardiolipin antibodies a risk factor for coronary artery disease in chronic renal failure patients?
    Ucar E; Kuvandik G; Sert M; Kuvandik C; Temizkan A; Borazan A
    Ren Fail; 2008; 30(8):791-5. PubMed ID: 18791953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list.
    Akman B; Afsar B; Ataç FB; Ibis A; Arat Z; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Mar; 38(2):413-5. PubMed ID: 16549134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure.
    Ozmen S; Danis R; Akin D; Batun S
    Clin Nephrol; 2009 Sep; 72(3):193-8. PubMed ID: 19761724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic profile of end-stage renal failure patients.
    Sezer S; Ozdemir N; Güz G; Turan M; Arslan S; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3359-60. PubMed ID: 10616506
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum epidemiological trial on the prevalence of the anti-cytomegalovirus antibodies in patients under substitutive treatment with hemodialysis and CAPD.
    Spisni C; Stingone A; Di Vito R; Rondinella I; D'Amario C; Tucci E; Caravelli L; D'Angelo B; Cerasoli P
    Nephron; 1992; 61(3):373-4. PubMed ID: 1323796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.